Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer

Pancreatic cancer, the fourth leading cause of cancer death in the United States, is frequently associated with the amplification and deletion of specific oncogenes and tumor-suppressor genes (TSGs), respectively. To identify such novel alterations and to discover the underlying genes, we performed...

Full description

Bibliographic Details
Main Authors: Murali D. Bashyam, Ryan Bair, Young H. Kim, Pei Wang, Tina Hernandez-Boussard, Collins A. Karikari, Robert Tibshirani, Anirban Maitra, Jonathan R. Pollack
Format: Article
Language:English
Published: Elsevier 2005-06-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558605800764
id doaj-a08843602edd4c5996e68b59a7bdd279
record_format Article
spelling doaj-a08843602edd4c5996e68b59a7bdd2792020-11-25T00:06:30ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022005-06-017655656210.1593/neo.04586Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic CancerMurali D. Bashyam0Ryan Bair1Young H. Kim2Pei Wang3Tina Hernandez-Boussard4Collins A. Karikari5Robert Tibshirani6Anirban Maitra7Jonathan R. Pollack8Department of Pathology, Stanford University, Stanford, CA, USADepartment of Pathology, Stanford University, Stanford, CA, USADepartment of Pathology, Stanford University, Stanford, CA, USADepartment of Statistics, Stanford University, Stanford, CA, USADepartment of Genetics, Stanford University, Stanford, CA, USADepartment of Pathology, The Johns Hopkins University, Baltimore, MD, USADepartment of Statistics, Stanford University, Stanford, CA, USADepartment of Pathology, The Johns Hopkins University, Baltimore, MD, USADepartment of Pathology, Stanford University, Stanford, CA, USA Pancreatic cancer, the fourth leading cause of cancer death in the United States, is frequently associated with the amplification and deletion of specific oncogenes and tumor-suppressor genes (TSGs), respectively. To identify such novel alterations and to discover the underlying genes, we performed comparative genomic hybridization on a set of 22 human pancreatic cancer cell lines, using cDNA microarrays measuring ~ 26,000 human genes (thereby providing an average mapping resolution of <60 kb). To define the subset of amplified and deleted genes with correspondingly altered expression, we also profiled mRNA levels in parallel using the same cDNA microarray platform. In total, we identified 14 high-level amplifications (38–4934 kb in size) and 15 homozygous deletions (46–725 kb). We discovered novel localized amplicons, suggesting previously unrecognized candidate oncogenes at 6p21, 7q21 (SMURF1, TRRAP), 11q22 (BIRC2, BIRC3), 12p12, 14q24 (TGFB3), 17ql2, and 19q13. Likewise, we identified novel polymerase chain reaction-validated homozygous deletions indicating new candidate TSGs at 6q25, 8p23, 8p22 (TUSC3), 9q33 (TNC, TNFSF15),10q22, 10q24 (CHUK), 11p15 (DKK3), 16q23, 18q23, 21q22 (PRDM15, ANKRD3), and Xp1l. Our findings suggest candidate genes and pathways, which may contribute to the development or progression of pancreatic cancer. http://www.sciencedirect.com/science/article/pii/S1476558605800764Pancreatic cancerarray CGHcomparative genomic hybridizationexpression profilingDNA amplification
collection DOAJ
language English
format Article
sources DOAJ
author Murali D. Bashyam
Ryan Bair
Young H. Kim
Pei Wang
Tina Hernandez-Boussard
Collins A. Karikari
Robert Tibshirani
Anirban Maitra
Jonathan R. Pollack
spellingShingle Murali D. Bashyam
Ryan Bair
Young H. Kim
Pei Wang
Tina Hernandez-Boussard
Collins A. Karikari
Robert Tibshirani
Anirban Maitra
Jonathan R. Pollack
Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer
Neoplasia: An International Journal for Oncology Research
Pancreatic cancer
array CGH
comparative genomic hybridization
expression profiling
DNA amplification
author_facet Murali D. Bashyam
Ryan Bair
Young H. Kim
Pei Wang
Tina Hernandez-Boussard
Collins A. Karikari
Robert Tibshirani
Anirban Maitra
Jonathan R. Pollack
author_sort Murali D. Bashyam
title Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer
title_short Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer
title_full Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer
title_fullStr Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer
title_full_unstemmed Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer
title_sort array-based comparative genomic hybridization identifies localized dna amplifications and homozygous deletions in pancreatic cancer
publisher Elsevier
series Neoplasia: An International Journal for Oncology Research
issn 1476-5586
1522-8002
publishDate 2005-06-01
description Pancreatic cancer, the fourth leading cause of cancer death in the United States, is frequently associated with the amplification and deletion of specific oncogenes and tumor-suppressor genes (TSGs), respectively. To identify such novel alterations and to discover the underlying genes, we performed comparative genomic hybridization on a set of 22 human pancreatic cancer cell lines, using cDNA microarrays measuring ~ 26,000 human genes (thereby providing an average mapping resolution of <60 kb). To define the subset of amplified and deleted genes with correspondingly altered expression, we also profiled mRNA levels in parallel using the same cDNA microarray platform. In total, we identified 14 high-level amplifications (38–4934 kb in size) and 15 homozygous deletions (46–725 kb). We discovered novel localized amplicons, suggesting previously unrecognized candidate oncogenes at 6p21, 7q21 (SMURF1, TRRAP), 11q22 (BIRC2, BIRC3), 12p12, 14q24 (TGFB3), 17ql2, and 19q13. Likewise, we identified novel polymerase chain reaction-validated homozygous deletions indicating new candidate TSGs at 6q25, 8p23, 8p22 (TUSC3), 9q33 (TNC, TNFSF15),10q22, 10q24 (CHUK), 11p15 (DKK3), 16q23, 18q23, 21q22 (PRDM15, ANKRD3), and Xp1l. Our findings suggest candidate genes and pathways, which may contribute to the development or progression of pancreatic cancer.
topic Pancreatic cancer
array CGH
comparative genomic hybridization
expression profiling
DNA amplification
url http://www.sciencedirect.com/science/article/pii/S1476558605800764
work_keys_str_mv AT muralidbashyam arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
AT ryanbair arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
AT younghkim arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
AT peiwang arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
AT tinahernandezboussard arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
AT collinsakarikari arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
AT roberttibshirani arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
AT anirbanmaitra arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
AT jonathanrpollack arraybasedcomparativegenomichybridizationidentifieslocalizeddnaamplificationsandhomozygousdeletionsinpancreaticcancer
_version_ 1725421713114529792